ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 167 filers reported holding ANIKA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $3,714,800 | -51.9% | 125,500 | -61.3% | 0.02% | -52.6% |
Q3 2022 | $7,728,000 | -12.2% | 324,700 | -17.6% | 0.04% | -2.6% |
Q2 2022 | $8,799,000 | +11.5% | 394,200 | +25.4% | 0.04% | +44.4% |
Q1 2022 | $7,892,000 | +382.1% | 314,300 | +587.7% | 0.03% | +800.0% |
Q4 2021 | $1,637,000 | -5.0% | 45,700 | +19.9% | 0.00% | -40.0% |
Q4 2020 | $1,724,000 | – | 38,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Trigran Investments, Inc. | 1,154,183 | $25,761,000 | 3.00% |
CAPITAL MANAGEMENT CORP /VA | 275,130 | $6,141,000 | 1.52% |
Kent Lake Capital LLC | 98,570 | $2,200,000 | 1.21% |
DIKER MANAGEMENT LLC | 21,835 | $487,000 | 0.60% |
Portolan Capital Management | 235,972 | $5,267,000 | 0.53% |
Riverwater Partners LLC | 12,466 | $278,000 | 0.28% |
Ranger Investment Management | 139,661 | $3,117,000 | 0.24% |
Invenomic Capital Management LP | 144,287 | $3,220,000 | 0.23% |
CHATHAM CAPITAL GROUP, INC. | 23,787 | $531,000 | 0.12% |
Teton Advisors, Inc. | 22,000 | $491,000 | 0.10% |